Rivaroxaban Vascular Zentiva 2
Rivaroxaban Vascular Zentiva 2 is a medicine authorised by Swissmedic under authorisation number 68749. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 June 2024 and the authorisation is limited until 19 June 2029. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 68749 |
|---|---|
| Name | Rivaroxaban Vascular Zentiva 2 |
| Full name | Rivaroxaban Vascular Zentiva 2,5 mg, Filmtabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 20 June 2024 |
| Authorisation validity | 19 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban Vascular Zentiva 2,5 mg, Filmtabletten | B | 20 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 56 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 4 | 196 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban Vascular Zentiva 2 authorised in Switzerland?
Yes. Rivaroxaban Vascular Zentiva 2 is authorised by Swissmedic under authorisation number 68749, data as of 01 September 2026. The authorisation is limited until 19 June 2029.
Which dispensing category does Rivaroxaban Vascular Zentiva 2 have?
Rivaroxaban Vascular Zentiva 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban Vascular Zentiva 2?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.